Nakazawa N, Sano A, Kumakura Y, Yamashita T, et al. Prognostic Nutrition Index as a Biomarker for Treatment Sensitivity to Chemotherapy and Nivolumab as the First-Line Treatment in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study. Oncology 2024 Oct 24:1-17. doi: 10.1159/000541544.
PMID: 39447553